UTMD vs. DHR

Last updated Apr 1, 2026

Compare and contrast key facts about Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR).

Performance

UTMD vs. DHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). The values are adjusted to include any dividend payments, if applicable.

UTMD vs. DHR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UTMD Utah Medical Products, Inc.	11.31%	-7.01%	-25.69%	-15.10%	1.87%	21.97%	-20.87%	31.46%	3.24%	13.59%
DHR Danaher Corporation	-17.00%	0.35%	-0.35%	-1.22%	-19.02%	48.57%	45.34%	49.55%	11.80%	20.01%

Fundamentals

Market Cap UTMD : $198.24M DHR : $134.81B
EPS UTMD : $3.51 DHR : $5.06
PE Ratio UTMD : 17.67 DHR : 37.49
PS Ratio UTMD : 5.18 DHR : 5.51
PB Ratio UTMD : 1.66 DHR : 2.57
Total Revenue (TTM) UTMD : $38.52M DHR : $24.57B
Gross Profit (TTM) UTMD : $20.39M DHR : $14.97B
EBITDA (TTM) UTMD : $16.68M DHR : $7.02B

Returns By Period

In the year-to-date period, UTMD achieves a 11.31% return, which is significantly higher than DHR's -17.00% return. Over the past 10 years, UTMD has underperformed DHR with an annualized return of 1.58%, while DHR has yielded a comparatively higher 12.00% annualized return.

UTMD

• 1D: -4.32%
• 1M: -6.48%
• YTD: 11.31%
• 6M: -0.54%
• 1Y: 12.93%
• 3Y*: -11.61%
• 5Y*: -5.02%
• 10Y*: 1.58%

DHR

• 1D: 3.11%
• 1M: -9.80%
• YTD: -17.00%
• 6M: -4.03%
• 1Y: -6.87%
• 3Y*: -4.81%
• 5Y*: -0.55%
• 10Y*: 12.00%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

UTMD vs. DHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTMD

UTMD Risk / Return Rank: 58
UTMD Sharpe Ratio Rank: 62
UTMD Sortino Ratio Rank: 55
UTMD Omega Ratio Rank: 51
UTMD Calmar Ratio Rank: 60
UTMD Martin Ratio Rank: 61

DHR

DHR Risk / Return Rank: 30
DHR Sharpe Ratio Rank: 32
DHR Sortino Ratio Rank: 28
DHR Omega Ratio Rank: 29
DHR Calmar Ratio Rank: 33
DHR Martin Ratio Rank: 27

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTMD vs. DHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UTMD	DHR	Difference
Sharpe ratio Return per unit of total volatility	0.55	-0.21	+0.76
Sortino ratio Return per unit of downside risk	0.97	-0.09	+1.06
Omega ratio Gain probability vs. loss probability	1.11	0.99	+0.12
Calmar ratio Return relative to maximum drawdown	0.80	-0.29	+1.10
Martin ratio Return relative to average drawdown	2.08	-0.87	+2.95
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UTMD vs. DHR - Sharpe Ratio Comparison

The current UTMD Sharpe Ratio is 0.55, which is higher than the DHR Sharpe Ratio of -0.21. The chart below compares the historical Sharpe Ratios of UTMD and DHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UTMD	DHR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.55	-0.21	+0.76
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	-0.02	-0.16
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.05	0.48	-0.42
Sharpe Ratio (All Time) Calculated using the full available price history	0.36	0.65	-0.30

Correlation

The correlation between UTMD and DHR is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

UTMD vs. DHR - Dividend Comparison

UTMD's dividend yield for the trailing twelve months is around 1.98%, more than DHR's 0.72% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
UTMD Utah Medical Products, Inc.	1.98%	2.19%	1.96%	1.41%	1.16%	2.86%	1.33%	1.02%	1.31%	1.31%	1.44%	1.75%
DHR Danaher Corporation	0.72%	0.56%	0.47%	12.64%	0.38%	0.26%	0.32%	0.44%	0.62%	0.60%	32.55%	0.58%

Drawdowns

UTMD vs. DHR - Drawdown Comparison

The maximum UTMD drawdown since its inception was -55.58%, which is greater than DHR's maximum drawdown of -45.80%. Use the drawdown chart below to compare losses from any high point for UTMD and DHR.

Drawdown Indicators

	UTMD	DHR	Difference
Max Drawdown Largest peak-to-trough decline	-55.58%	-45.80%	-9.78%
Max Drawdown (1Y) Largest decline over 1 year	-15.77%	-24.85%	+9.08%
Max Drawdown (5Y) Largest decline over 5 years	-55.58%	-39.81%	-15.77%
Max Drawdown (10Y) Largest decline over 10 years	-55.58%	-39.81%	-15.77%
Current Drawdown Current decline from peak	-45.68%	-34.20%	-11.48%
Average Drawdown Average peak-to-trough decline	-14.90%	-10.08%	-4.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.10%	8.34%	-2.24%

Volatility

UTMD vs. DHR - Volatility Comparison

The current volatility for Utah Medical Products, Inc. (UTMD) is 8.45%, while Danaher Corporation (DHR) has a volatility of 8.93%. This indicates that UTMD experiences smaller price fluctuations and is considered to be less risky than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UTMD	DHR	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.45%	8.93%	-0.48%
Volatility (6M) Calculated over the trailing 6-month period	16.22%	20.17%	-3.95%
Volatility (1Y) Calculated over the trailing 1-year period	23.60%	32.45%	-8.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.52%	27.75%	-0.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.62%	25.24%	+5.38%

Financials

UTMD vs. DHR - Profitability Comparison

The chart below illustrates the profitability comparison between Utah Medical Products, Inc. and Danaher Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

UTMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Utah Medical Products, Inc. reported a gross profit of 4.73M and revenue of 9.04M. Therefore, the gross margin over that period was 52.3%.

DHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a gross profit of 3.97B and revenue of 6.84B. Therefore, the gross margin over that period was 58.0%.

UTMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Utah Medical Products, Inc. reported an operating income of 2.44M and revenue of 9.04M, resulting in an operating margin of 27.0%.

DHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported an operating income of 1.50B and revenue of 6.84B, resulting in an operating margin of 22.0%.

UTMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Utah Medical Products, Inc. reported a net income of 2.57M and revenue of 9.04M, resulting in a net margin of 28.4%.

DHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a net income of 1.20B and revenue of 6.84B, resulting in a net margin of 17.5%.